4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-15-009386
CIK 0001411158operating
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:10 PM ET
Size
5.2 KB
Accession
0001209191-15-009386
Insider Transaction Report
Form 4
Maples Kirk R
Senior VP Program Mgt
Transactions
- Sale
Common Stock
2015-02-02$37.41/sh−600$22,448→ 4,600 total
Footnotes (3)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $37.07 to $37.68, inclusive.
- [F3]Includes 1,000 shares purchased on January 30, 2015 pursuant to the Issuer's ESPP.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:10 PM ET
- Size
- 5.2 KB